Sign up
Log in
11 Health Care Stocks Moving In Thursday's Intraday Session
Share
Listen to the news

Gainers

  • Protagenic Therapeutics (NASDAQ:PTIX) shares rose 85.8% to $0.42 during Thursday's regular session. The market value of their outstanding shares is at $3.0 million. As per the news, the Q4 earnings report came out 3 days ago.
  • OSR Holdings (NASDAQ:OSRH) shares moved upwards by 59.18% to $2.34. The market value of their outstanding shares is at $45.1 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares rose 45.67% to $2.01. The company's market cap stands at $2.9 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) shares rose 38.75% to $3.88. The market value of their outstanding shares is at $6.2 million.
  • Genprex (NASDAQ:GNPX) shares moved upwards by 31.33% to $0.39. The market value of their outstanding shares is at $3.2 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares increased by 30.76% to $4.25. The company's market cap stands at $2.6 million.

Losers

  • Aldeyra Therapeutics (NASDAQ:ALDX) stock declined by 73.7% to $1.4 during Thursday's regular session. The company's market cap stands at $83.3 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares decreased by 61.61% to $0.47.
  • RxSight (NASDAQ:RXST) stock fell 39.29% to $15.86. The market value of their outstanding shares is at $642.1 million.
  • Impact BioMedical (AMEX:IBO) stock decreased by 18.3% to $0.47. The market value of their outstanding shares is at $5.3 million.
  • CervoMed (NASDAQ:CRVO) shares decreased by 17.75% to $11.17. The market value of their outstanding shares is at $97.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.